SNX16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.195600E-01
Normal-vs-Stage2
6.352800E-01
Normal-vs-Stage3
3.169000E-01
Normal-vs-Stage4
3.927600E-01
Stage1-vs-Stage2
3.883400E-01
Stage1-vs-Stage3
4.473200E-01
Stage1-vs-Stage4
5.151400E-01
Stage2-vs-Stage3
5.922000E-01
Stage2-vs-Stage4
6.001800E-02
Stage3-vs-Stage4
1.378160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.189400E-01
Normal-vs-AfricanAmerican
8.919400E-01
Normal-vs-Asian
5.016600E-01
Caucasian-vs-AfricanAmerican
3.349600E-01
Caucasian-vs-Asian
4.934600E-01
AfricanAmerican-vs-Asian
3.515800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.190800E-01
Normal-vs-Female
7.865800E-01
Male-vs-Female
4.205000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.047200E-01
Normal-vs-Age(41-60Yrs)
9.728400E-01
Normal-vs-Age(61-80Yrs)
6.140800E-01
Normal-vs-Age(81-100Yrs)
1.820350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.010400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.417800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.419400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.204200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.013600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.730200E-01
Normal-vs-Daily Drinker
5.536400E-02
Normal-vs-Weekly Drinker
3.776200E-01
Normal-vs-Occasional Drinker
9.747200E-01
Normal-vs-Social Drinker
6.938200E-01
Non Drinker-vs-Daily Drinker
1.662630E-01
Non Drinker-vs-Weekly Drinker
7.932600E-01
Non Drinker-vs-Occasional Drinker
1.300760E-01
Non Drinker-vs-Social Drinker
4.430400E-01
Daily Drinker-vs-Weekly Drinker
1.580030E-01
Daily Drinker-vs-Occasional Drinker
2.337600E-02
Daily Drinker-vs-Social Drinker
1.383430E-01
Weekly Drinker-vs-Occasional Drinker
2.518800E-01
Weekly Drinker-vs-Social Drinker
6.732200E-01
Occasional Drinker-vs-Social Drinker
4.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.040400E-01
Normal-vs-Grade 2
3.073000E-01
Normal-vs-Grade 3
5.401600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.729000E-01
Grade 1-vs-Grade 3
8.052000E-01
Grade 1-vs-Grade 4
6.040400E-01
Grade 2-vs-Grade 3
4.649600E-01
Grade 2-vs-Grade 4
3.073000E-01
Grade 3-vs-Grade 4
5.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.747800E-01
Normal-vs-NonDiabetic
5.103000E-01
Diabetic-vs-NonDiabetic
5.735400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.995600E-02
Normal-vs-NoPancreatitis
5.343600E-01
Pancreatitis-vs-NoPancreatitis
1.154170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.232200E-01
Normal-vs-N1
6.970000E-01
N0-vs-N1
8.243000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.779400E-01
Normal-vs-TP53-NonMutant
7.478600E-01
TP53-Mutant-vs-TP53-NonMutant
2.683600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
